{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:46Z","timestamp":1793047186046,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Activated PI3-kinase-\u03b4 syndrome 2 (APDS2) is caused by autosomal dominant mutations in the <jats:italic>PIK3R1<\/jats:italic> gene encoding the p85\u03b1, p55\u03b1, and p50\u03b1 regulatory subunits. Most diagnosed APDS2 patients carry mutations affecting either the splice donor or splice acceptor sites of exon 11 of the <jats:italic>PIK3R1<\/jats:italic> gene responsible for an alternative splice product and a shortened protein. The clinical presentation of APDS2 patients is highly variable, ranging from mild to profound combined immunodeficiency features as massive lymphoproliferation, increased susceptibility to bacterial and viral infections, bronchiectasis, autoimmune manifestations, and occurrence of cancer. Non-immunological features such as growth retardation and neurodevelopmental delay have been reported for APDS2 patients. Here, we describe a patient suffering from an APDS2 associated with a Smith\u2013Magenis syndrome (SMS), a complex genetic disorder affecting, among others, neurological manifestations and review the literature describing neurodevelopmental impacts in APDS2 and other PIDs\/monogenetic disorders associated with dysregulated PI3K signaling.<\/jats:p>","DOI":"10.3389\/fped.2021.688022","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T05:47:23Z","timestamp":1624513643000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Two Monogenetic Disorders, Activated PI3-Kinase-\u03b4 Syndrome 2 and Smith\u2013Magenis Syndrome, in One Patient: Case Report and a Literature Review of Neurodevelopmental Impact in Primary Immunodeficiencies Associated With Disturbed PI3K Signaling"],"prefix":"10.3389","volume":"9","author":[{"given":"Nidia","family":"Moreno-Corona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Chentout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Poggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romane","family":"Thouenon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Parisot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou Le","family":"Mouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Durandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Azarnoush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Kracker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-Kinase gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"124","author":"Deau","year":"2014","journal-title":"J Clin Invest."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.03.022","article-title":"Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase \u03b4 syndrome 2: a cohort study","author":"Elkaim","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase \u03b4 syndrome: a large patient cohort study","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2015.04.014","article-title":"Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype","volume":"159","author":"Lougaris","year":"2015","journal-title":"Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/pai.12585","article-title":"Activated PI3K\u03b4 syndrome type 2: two patients, a novel mutation, and review of the literature","volume":"27","author":"Olbrich","year":"2016","journal-title":"Pediatr Allergy Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0043-104218","article-title":"Variant PIK3R1 hypermorphic mutation and clinical phenotypes in a family with short statures, mild immunodeficiency and lymphoma","volume":"229","author":"Hauck","year":"2017","journal-title":"Klin Padiatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41436-018-0012-x","article-title":"Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency","volume":"21","author":"Abolhassani","year":"2019","journal-title":"Genet Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K","volume":"211","author":"Lucas","year":"2014","journal-title":"J Exp Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.1617244114","article-title":"Conformational disruption of PI3K\u03b4 regulation by immunodeficiency mutations in PIK3CD and PIK3R1","volume":"114","author":"Dornan","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.01.004","article-title":"Genetic defects in PI3K\u03b4 affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections","volume":"176","author":"Wentink","year":"2017","journal-title":"Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41467-017-00933-6","article-title":"Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability","volume":"8","author":"Reijnders","year":"2017","journal-title":"Nat Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jaci.2019.03.017","article-title":"PI3K pathway defects leading to immunodeficiency and immune dysregulation","volume":"143","author":"Nunes-Santos","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/sj.ejhg.5202009","article-title":"Smith\u2013Magenis syndrome","volume":"16","author":"Elsea","year":"2008","journal-title":"Eur J Hum Genet."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.01.028","article-title":"Smith-Magenis syndrome patients often display antibody deficiency but not other immune pathologies","author":"Perkins","year":"2017","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000357359","article-title":"Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11","author":"Dubourg","year":"2014","journal-title":"Mol Syndromol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/ng1126","article-title":"Mutations in RAI1 associated with Smith\u2013Magenis syndrome","volume":"33","author":"Slager","year":"2003","journal-title":"Nat Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jaci.2017.10.033","article-title":"Dual loss of p110\u03b4 PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic features","volume":"142","author":"Sharfe","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.06.039","article-title":"Primary immunodeficiency disorder caused by phosphoinositide 3\u2013kinase \u03b4 deficiency","author":"Sogkas","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1084\/jem.20190678","article-title":"Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells","volume":"216","author":"Rodriguez","year":"2019","journal-title":"J Exp Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.3324\/haematol.2018.208397","article-title":"Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase \u03b4","volume":"104","author":"Swan","year":"2019","journal-title":"Haematologica."},{"key":"B23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.20112533","article-title":"Agammaglobulinemia and absent B lineage cells in a patient lacking the p85\u03b1 subunit of PI3K","volume":"209","author":"Conley","year":"2012","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10875-017-0462-y","article-title":"Autosomal recessive agammaglobulinemia due to a homozygous mutation in PIK3R1","volume":"38","author":"Tang","year":"2018","journal-title":"J Clin Immunol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.15.426862","article-title":"Activated PI3K\u03b4 syndrome, an immunodeficiency disorder, leads to sensorimotor deficits recapitulated in a murine model","year":"2021","journal-title":"Neuroscience."},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13052-017-0362-z","article-title":"SHORT syndrome in a two-year-old girl \u2013 case report","volume":"43","author":"Klatka","year":"2017","journal-title":"Ital J Pediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT Syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am J Hum Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2015-103266","article-title":"Cowden's syndrome with immunodeficiency","volume":"52","author":"Browning","year":"2015","journal-title":"J Med Genet."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.010","article-title":"Increased PI3K\/Akt activity and deregulated humoral immune response in human PTEN deficiency","author":"Driessen","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.03.055","article-title":"Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase \u03b4 syndrome\u2013like immunodeficiency","author":"Tsujita","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.tranon.2018.11.003","article-title":"PTEN Hamartoma tumor syndrome and immune dysregulation","volume":"12","author":"Eissing","year":"2019","journal-title":"Transl Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/9682803","article-title":"De novo PTEN mutation in a young boy with cutaneous vasculitis","volume":"2017","author":"Mauro","year":"2017","journal-title":"Case Rep Pediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/GIM.0b013e31818fd762","article-title":"The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly","volume":"11","author":"Varga","year":"2009","journal-title":"Genet Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10875-013-9869-2","article-title":"Identification of a phos-phoinositide-3 kinase (PI-3K) p110d (PIK3CD) deficient individual","volume":"33","author":"Zhang","year":"2013","journal-title":"J Clin Immunol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.688022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T05:47:24Z","timestamp":1624513644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.688022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":35,"alternative-id":["10.3389\/fped.2021.688022"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.688022","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"article-number":"688022"}}